Provided by Tiger Trade Technology Pte. Ltd.

LifeStance Health Group, Inc.

12.15
-0.1300-1.06%
Post-market: 12.250.1000+0.82%19:42 EDT
Volume:4.43M
Turnover:54.01M
Market Cap:4.64B
PE:94.30
High:12.48
Open:12.21
Low:12.01
Close:12.28
52wk High:12.97
52wk Low:4.77
Shares:382.06M
Float Shares:249.00M
Volume Ratio:1.59
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1288
EPS(LYR):0.0200
ROE:3.43%
ROA:2.32%
PB:3.14
PE(LYR):607.50

Loading ...

Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]